Cor Vasa 2018, 60(5):e452-e455 | DOI: 10.1016/j.crvasa.2017.06.011

Mexiletine as one effective alternative for antiarrhythmic drugs and ablation resistant electrical storm - A case report

Martyna Zaleskaa, Maria Różańskaa, Olga Możeńskaa, Dariusz Artur Kosiorb,*
a Department of Cardiology and Hypertension, Central Research Hospital, The Ministry of the Interior, Wołoska 137, 02-507 Warsaw, Poland
b Department of Applied Physiology, Mossakowski Medical Research Centre, Polish Academy of Sciences, Pawińskiego 5, 02-106 Warsaw, Poland

We present case of 78-year-old male transferred to our Department due to multiple episodes of malignant ventricular arrhythmias refractory to previous antiarrhythmic treatments (device settings optimization, amiodarone treatment, lidocaine infusion and optimal pharmacotherapy). Additionally, patient had ischemic end-stage heart failure and implanted CRT-D. We excluded secondary causes of electrical storm and due to inefficacy of medical therapy, we applied radiofrequency ablation. During 1st day after procedure life-threatening VT/VF recurred. As our last choice, we modified therapy and introduced mexiletine, what resulted in complete disappearance of complex ventricular arrhythmias.
In case of amiodarone inefficacy mexiletine may be considered effective alternative antiarrhythmic drug.

Keywords: Ablation; Heart failure; Implantable cardioverter-defibrillator; Mexiletine; Ventricular arrhythmia

Received: December 29, 2016; Accepted: June 21, 2017; Published: October 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zaleska M, Różańska M, Możeńska O, Kosior DA. Mexiletine as one effective alternative for antiarrhythmic drugs and ablation resistant electrical storm - A case report. Cor Vasa. 2018;60(5):e452-455. doi: 10.1016/j.crvasa.2017.06.011.
Download citation

References

  1. P.R. Kowey, An overview of antiarrhythmic drug management of electrical storm, Canadian Journal of Cardiology 12 (Suppl. B) (1996) 3B-8B, discussion 27B-28B. Go to PubMed...
  2. S.J. Connolly, P. Dorian, R.S. Roberts, et al., Comparison of β-blockers, amiodarone plus β-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC study: a randomized trial, Journal of the American Medical Association 295 (2006) 165-171. Go to original source... Go to PubMed...
  3. P. Nordbeck, B. Seidl, B. Fey, et al., Effect of cardiac resynchronization therapy on the incidence of electrical storm, International Journal of Cardiology 143 (2010) 330-336. Go to original source... Go to PubMed...
  4. M. Gasparini, M. Lunati, M. Landolina, et al., Electrical storm in patients with biventricular implantable cardioverter defibrillator: incidence, predictors, and prognostic implications, American Heart Journal 156 (2008) 847-854. Go to original source... Go to PubMed...
  5. F. Streitner, J. Kuschyk, C. Veltmann, et al., Predictors of electrical storm recurrences in patients with implantable cardioverter-defibrillators, Europace 13 (2011) 668-674. Go to original source... Go to PubMed...
  6. J.M. Guerra, J. Wu, J.M. Miller, W.J. Groh, Increase in ventricular tachycardia frequency after biventricular implantable cardioverter defibrillator upgrade, Journal of Cardiovascular Electrophysiology 14 (2003) 1245-1247. Go to original source... Go to PubMed...
  7. V.A. Medina-Ravell, R.S. Lankipalli, G.X. Yan, et al., Effect of epicardial or biventricular pacing to prolong QT interval and increase transmural dispersion of repolarization: does resynchronization therapy pose a risk for patients predisposed to long QT or torsade de pointes? Circulation 107 (2003) 740-746. Go to original source... Go to PubMed...
  8. A. Di Cori, M.G. Bongiorni, G. Arena, et al., New-onset ventricular tachycardia after cardiac resynchronization therapy, Journal of Interventional Cardiac Electrophysiology 12 (2005) 231-235. Go to original source... Go to PubMed...
  9. A. Mykytsey, P. Maheshwari, G. Dhar, et al., Ventricular tachycardia induced by biventricular pacing in patient with severe ischemic cardiomyopathy, Journal of Cardiovascular Electrophysiology 16 (2005) 655-658. Go to original source... Go to PubMed...
  10. B.K. Kantharia, J.A. Patel, B.S. Nagra, et al., Electrical storm of monomorphic ventricular tachycardia after a cardiac-resynchronization-therapy-defibrillator upgrade, Europace 8 (2006) 625-628. Go to original source... Go to PubMed...
  11. M. Izquierdo, R. Ruiz-Granell, A. Ferrero, et al., Ablation or conservative management of electrical storm due to monomorphic ventricular tachycardia: differences in outcome, Europace 14 (2012) 1734-1739. Go to original source... Go to PubMed...
  12. H.M. Nayak, R.J. Verdino, A.M. Russo, et al., Ventricular tachycardia storm after initiation of biventricular pacing: incidence, clinical characteristics, management, and outcome, Journal of Cardiovascular Electrophysiology 19 (2008) 708-715. Go to original source... Go to PubMed...
  13. S.G. Priori, C. Blomstrom-Lundqvist, A. Mazzanti, et al., 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), European Heart Journal 36 (2015) 2793-2867. Go to original source... Go to PubMed...
  14. H. Murata, Y. Miyauchi, M. Hayashi, et al., Clinical and electrocardiographic characteristics of electrical storms due to monomorphic ventricular tachycardia refractory to intravenous amiodarone, Circulation Journal 79 (2015) 2130-2137. Go to original source... Go to PubMed...
  15. D. Gao, H. Van Herendael, L. Alshengeiti, et al., Mexiletine as an adjunctive therapy to amiodarone reduces the frequency of ventricular tachyarrhythmia events in patients with an implantable defibrillator, Journal of Cardiovascular Pharmacology 62 (2013) 199-204. Go to original source... Go to PubMed...
  16. H. Morita, K. Hirabayashi, S. Nozaki, et al., Chronic effect of oral mexiletine administration on left ventricular contractility in patients with congestive heart failure: a study based on mitral regurgitant flow velocity measured by continuous-wave Doppler echocardiography, Journal of Clinical Pharmacology 35 (1995) 478-483. Go to original source... Go to PubMed...
  17. S.S. Gottlieb, M. Weinberg, Cardiodepressant effects of mexiletine in patients with severe left ventricular dysfunction, European Heart Journal 13 (1992) 22-27. Go to original source... Go to PubMed...
  18. M. Kobayashi, K. Fukumoto, K. Ueno, Effect of congestive heart failure on mexiletine pharmacokinetics in a Japanese population, Biological & Pharmaceutical Bulletin 29 (2006) 2267-2269. Go to original source... Go to PubMed...
  19. D. Fedida, P.M. Orth, J.C. Hesketh, et al., The role of late I and antiarrhythmic drugs in EAD formation and termination in Purkinje fibers, Journal of Cardiovascular Electrophysiology 17 (Suppl. 1) (2006) S71-S78. Go to original source... Go to PubMed...
  20. K. Inuo, S. Niwano, Y. Morohoshi, et al., Cardioprotective effect of mexiletine in acute myocardial ischemia. Studies in the rabbit closed chest ischemia model, Circulation Journal 66 (2002) 403-410. Go to original source... Go to PubMed...




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.